Accelera Innovations

Accelera Innovations Altman Z-Score

The Altman Z-Score of Accelera Innovations (ACNV) as of Nov 5, 2026 is -9,598.43. In the previous year, Altman Z-Score was -250.83 — a change of 3,726.72% (lower).

Altman Z-Score

-9,598.43

YoY

3,726.72%

Last updated:

Altman Z-Score of Accelera Innovations is 2016 -9,598.43 . Altman Z-Score of Accelera Innovations was 2015 -250.83 . It decreases by 3,726.72% lower compared to the previous year.

The Accelera Innovations Altman Z-Score history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Altman Z-Score
Date
Altman Z-Score
Jan 1, 2014
-217.66 USD
Jan 1, 2015
-250.83 USD
Jan 1, 2016
-9,598.43 USD
The Accelera Innovations Altman Z-Score history
YEARAltman Z-ScoreYoY
-9,598.43+3,726.72%
-250.83+15.24%
-217.66—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Accelera Innovations Stock analysis

What does Accelera Innovations do? Accelera Innovations, Inc. generates revenue through its subsidiary SCI Home Health, Inc., operating as Advance Lifecare Home Health, which provides personal care services to patients in the Chicago, Illinois area. The company focuses on acquiring businesses in the post-acute care patient services and information technology services sectors, with SCI Home Health representing its primary healthcare service offering. Revenue is derived from healthcare service contracts within the post-acute care segment, targeting patients requiring ongoing care after hospitalization. The company's business model centers on strategic acquisitions within the healthcare services industry, specifically targeting post-acute care providers and technology service firms. SCI Home Health, Inc. serves as the operational vehicle for delivering personal care services, while the company's acquisition strategy aims to expand its presence in the healthcare sector through targeted investments in complementary businesses. The firm's revenue streams are primarily tied to the delivery of home health services under the Advance Lifecare Home Health brand in the Chicago metropolitan area. Accelera Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accelera Innovations stock

Altman Z-Score of Accelera Innovations is -9,598.43 in 2016.

On Eulerpool you can find the complete historical development of Altman Z-Score Accelera Innovations since 2006 – with annual values, charts, and detailed analysis.

The Altman Z-Score predicts bankruptcy probability using five financial ratios. Scores above 3.0 indicate safety, below 1.8 suggests distress risk.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Accelera Innovations

All Key Metrics — Accelera Innovations